lactic acid has been researched along with galantamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Onaizi, MA; Barbash, S; Bartha, R; Guzman, MS; Hirata, PH; Kolisnyk, B; Nikolova, S; Prado, MA; Prado, VF; Soreq, H | 1 |
Calderó, G; Feiner-Gracia, N; Fornaguera, C; García-Celma, MJ; Solans, C | 1 |
2 other study(ies) available for lactic acid and galantamine
Article | Year |
---|---|
Forebrain deletion of the vesicular acetylcholine transporter results in deficits in executive function, metabolic, and RNA splicing abnormalities in the prefrontal cortex.
Topics: Acetylcholine; Animals; Aspartic Acid; Choice Behavior; Choline; Cholinesterase Inhibitors; Cognition Disorders; Executive Function; Galantamine; Inositol; Lactic Acid; Locomotion; Mice; Mice, Inbred C57BL; Mice, Transgenic; Photic Stimulation; Prefrontal Cortex; Psychomotor Performance; RNA Splicing; Taurine; Vesicular Acetylcholine Transport Proteins | 2013 |
Galantamine-loaded PLGA nanoparticles, from nano-emulsion templating, as novel advanced drug delivery systems to treat neurodegenerative diseases.
Topics: Cholinesterase Inhibitors; Drug Carriers; Emulsions; Galantamine; HeLa Cells; Humans; Lactic Acid; Nanoparticles; Neurodegenerative Diseases; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2015 |